Mercury Biopharmaceutical Corporation (6932.TWO)

TWD 13.3

(-2.56%)

Total Assets Summary of Mercury Biopharmaceutical Corporation

  • Mercury Biopharmaceutical Corporation's latest annual total assets in 2023 was 438.07 Million TWD , up 90.52% from previous year.
  • Mercury Biopharmaceutical Corporation's latest quarterly total assets in 2024 Q1 was 378.8 Million TWD , down -13.53% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported annual total assets of 229.93 Million TWD in 2022, up 1618.35% from previous year.
  • Mercury Biopharmaceutical Corporation reported annual total assets of 13.38 Million TWD in 2021, up 13694.85% from previous year.
  • Mercury Biopharmaceutical Corporation reported quarterly total assets of 378.8 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported quarterly total assets of 438.07 Million TWD for 2023 Q3, down -4.6% from previous quarter.

Annual Total Assets Chart of Mercury Biopharmaceutical Corporation (2023 - 2019)

Historical Annual Total Assets of Mercury Biopharmaceutical Corporation (2023 - 2019)

Year Total Assets Total Assets Growth
2023 438.07 Million TWD 90.52%
2022 229.93 Million TWD 1618.35%
2021 13.38 Million TWD 13694.85%
2020 97 Thousand TWD -38.22%
2019 157 Thousand TWD 0.0%

Peer Total Assets Comparison of Mercury Biopharmaceutical Corporation

Name Total Assets Total Assets Difference
Allied Biotech Corporation 2.07 Billion TWD 78.928%
GeneFerm Biotechnology Co., Ltd. 1.17 Billion TWD 62.729%
Easywell Biomedicals, Inc. 1.21 Billion TWD 63.908%
TTY Biopharm Company Limited 9.87 Billion TWD 95.564%
Synmosa Biopharma Corporation 11.72 Billion TWD 96.265%
Orient EuroPharma Co., Ltd. 10.81 Billion TWD 95.948%
Center Laboratories, Inc. 27 Billion TWD 98.378%
Tien Liang BioTech Co., Ltd. 654.03 Million TWD 33.02%
Orient Pharma Co., Ltd. 2.56 Billion TWD 82.906%
InnoPharmax Inc. 524.19 Million TWD 16.429%
Johnson Chemical Pharmaceutical Works Co., Ltd. 1.99 Billion TWD 78.019%
Excelsior Biopharma Inc. 1.57 Billion TWD 72.227%
DV Biomed Co., Ltd. 1.81 Billion TWD 75.832%
Foresee Pharmaceuticals Co., Ltd. 1.86 Billion TWD 76.466%
Handa Pharmaceuticals, Inc. 3.03 Billion TWD 85.576%
UniPharma Co., Ltd. 350.07 Million TWD -25.138%
Anxo Pharmaceutical Co., Ltd. 2.21 Billion TWD 80.254%
Alar Pharmaceuticals Inc. 973.2 Million TWD 54.986%
Winston Medical Supply Co., Ltd. 801.77 Million TWD 45.362%
Bioray Biotech Co., Ltd 542.64 Million TWD 19.271%
TSH Biopharm Corporation Limited 1.39 Billion TWD 68.706%